Table 10. Awareness, treatment and control of hypertension from various nationwide surveys in China.
| Study | Time | Age, yrs | Sampling method | Sample size | Awareness, % | Treatment, % | Control, % |
| ASR: age-standardized rate; WR: weighted rate. | |||||||
| National hypertension sampling survey | 1991 | ≥ 15 | Stratified random | 950,356 | 27.0 | 12.0 | 3.0 |
| China Health and Nutrition Survey | 2002 | ≥ 18 | Multistage stratified cluster random | 272,023 | 30.2 | 24.7 | 6.1 |
| Survey on the Status of Nutrition and Chronic Diseases of Chinese Residents |
2012 | ≥ 18 | Multistage stratified random | – | 46.5 | 41.1 | 13.8 |
| China Nutrition and Health Surveillance | 2010–2012 | ≥ 18 | Multistage stratified cluster random | 120,428 | 46.5 | 41.1 | 14.6 |
| Prevalence, awareness, treatment, and control of hypertension among Chinese working population |
2012–2013 | 18–60 | Multistage cluster | 37,856 | 57.6 (ASR 47.8) | 0.5 (ASR 20.6) | 11.2 (ASR 8.5) |
| China Hypertension Survey | 2012–2015 | ≥ 18 | Multistage stratified random | 451,755 | 51.6 (WR 46.9) | 45.8 (WR 40.7) | 16.8 (WR 15.3) |
| China Patient-centered Evaluative Assessment of Cardiac Events |
2014 | 35–75 | Purposive | 640,539 | 46.5 (ASR) | 38.1 (ASR) | 11.1 (ASR) |
| China Health and Nutrition Survey | 2015 | 20–79 | Multistage stratified cluster random | 8907 | 43.8 (ASR 27.2) | 39.2 (ASR 23.6) | 13.8 (ASR 8.4) |
| China Chronic Disease and Risk Factor Surveillance | 2018 | ≥ 18 | Multistage stratified cluster random | 179,873 | 41.0 (WR) | 34.9 (WR) | 11.0 (WR) |